Richard A. Barasch - 17 Jun 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role: Director
Signature: /s/ Mark Hueppelsheuser, Attorney-in-Fact for Richard Barasch
Issuer symbol: TOI
Transactions as of: 17 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 20 Jun 2025, 20:59:24 UTC
Previous filing: 28 Mar 2025
Next filing: 28 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
BARASCH RICHARD A	Director	C/O THE ONCOLOGY INSTITUTE INC., 18000 STUDEBAKER RD, SUITE 800, CERRITOS	/s/ Mark Hueppelsheuser, Attorney-in-Fact for Richard Barasch	20 Jun 2025	0001076341

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TOI	Common Stock	Conversion of derivative security	$0	+159,500	+9%	$0.000000	1,935,141	17 Jun 2025	Direct	F1, F2
transaction	TOI	Common Stock	Conversion of derivative security	$0	+620,400	+32%	$0.000000	2,555,541	18 Jun 2025	By Trust	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TOI	Class A Common Equivalent Preferred Stock	Conversion of derivative security	$0	-1,595	-100%	$0.000000	0	17 Jun 2025	Common Stock	159,500	$0.000000	Direct	F1, F2, F4
transaction	TOI	Class A Common Equivalent Preferred Stock	Conversion of derivative security	$0	-6,204	-100%	$0.000000	0	18 Jun 2025	Common Stock	620,400	$0.000000	By Trust	F1, F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the conversion of shares of Class A Common Equivalent Preferred Stock, par value $0.0001 (the "Preferred Stock") into shares of the Issuer's common stock, par value $0.0001 (the "Common Stock") in accordance with and pursuant to the Certificate of Designation of Preferences, Rights and Limitations of Series A Common Stock Equivalent Convertible Preferred Stock (the "Certificate of Designation").
F2	Each share of Preferred Stock is convertible into 100 shares of Common Stock. No consideration was paid in connection with the conversion.
F3	Securities are owned by Helen Barasch Family Trust #1, an affiliate of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein.
F4	Each share of Preferred Stock is convertible at any time at the option of the reporting person pursuant to the Certificate of Designation and has no expiration date.